View Older Stories View More Recent Stories

Nov 18, 2024 08:10AM Aclaris Therapeutics Announces $80 Million Private Placement
Nov 15, 2024 05:05PM Form SC 13G/A 4D Molecular Therapeutic Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:47PM Form SC 13G/A Ascendis Pharma A/S Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:47PM Form SC 13G/A RxSight, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:47PM Form SC 13G/A Taysha Gene Therapies, Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:47PM Form SC 13G/A Celcuity Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:47PM Form SC 13G/A UroGen Pharma Ltd. Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:47PM Form SC 13G/A SERA PROGNOSTICS, INC. Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:47PM Form SC 13G/A Dyne Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:46PM Form SC 13G/A 4D Molecular Therapeutic Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:46PM Form SC 13G/A Third Harmonic Bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:46PM Form SC 13G/A Tenaya Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:46PM Form SC 13G/A Alto Neuroscience, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:46PM Form SC 13G/A Enliven Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:46PM Form SC 13G/A Avidity Biosciences, Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:46PM Form SC 13G/A Unicycive Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:46PM Form SC 13G/A Structure Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:46PM Form SC 13G/A GH Research PLC Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:46PM Form SC 13G/A NewAmsterdam Pharma Co Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:46PM Form SC 13G/A Verona Pharma plc Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:46PM Form SC 13G/A BICYCLE THERAPEUTICS Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:46PM Form SC 13G/A Astria Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:46PM Form SC 13G/A Apogee Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:46PM Form SC 13G/A GERON CORP Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:46PM Form SC 13G/A Tourmaline Bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:46PM Form SC 13G/A Adicet Bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:46PM Form SC 13G/A Regulus Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:46PM Form SC 13G/A Vaxcyte, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:46PM Form SC 13G/A RHYTHM PHARMACEUTICALS, Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:46PM Form SC 13G/A Praxis Precision Medicin Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 04:34PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Sep 30
Nov 14, 2024 09:00AM Adela to Present Biological Insights into its Tissue-Agnostic Assay for Molecular Residual Disease Detection at the AACR Special Conference in Cancer Research
Nov 13, 2024 06:04PM Form SC 13D/A Tyra Biosciences, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 13, 2024 07:00AM Metsera Secures $215 Million Series B Financing to Further Accelerate Portfolio
Nov 12, 2024 04:16PM Form SC 13G BRIGHT MINDS BIOSCIENCES Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 12, 2024 07:45AM Hyku Biosciences Appoints John Gustofson to its Board of Directors
Nov 12, 2024 07:10AM Jeito Capital co-leads €164.5 million ($181.4 million) oversubscribed Series D financing in Alentis Therapeutics to advance clinical development of Anti-Claudin-1 ADCs in solid tumors
Nov 12, 2024 07:06AM Avalo Therapuetics (AVTX) Receives $69.4 Million in Proceeds from the Full Exercise of Private Placement Warrants
Nov 12, 2024 07:00AM Avalo Therapeutics Receives $69.4 Million in Proceeds from the Full Exercise of Private Placement Warrants
Nov 12, 2024 07:00AM Trace Neuroscience Launches With $101 Million Series A Financing to Expand Genomic Medicine for Neurodegenerative Diseases
Nov 12, 2024 07:00AM Alentis Therapeutics Raises $181.4 Million in an Oversubscribed Series D Financing to Advance the Clinical Development of Anti-Claudin-1 ADCs in Solid Tumors
Nov 12, 2024 07:00AM Novo Holdings co-leads $181.4 million Series D financing in Alentis Therapeutics to advance groundbreaking antibody-drug conjugates (ADCs) for solid tumours
Nov 6, 2024 05:42PM Form SC 13G GLYCOMIMETICS INC Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 6, 2024 04:17PM Form SC 13G Ensysce Biosciences, Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 5, 2024 04:17PM Form SC 13G Eledon Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 5, 2024 09:05AM Be Biopharma Announces Upcoming Presentation at the 66th American Society of Hematology (ASH) Annual Meeting
Nov 4, 2024 04:40PM Form SC 13D Septerna, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 4, 2024 02:42PM Bright Minds Biosciences (DRUG) Closes US$35 Million Non-Brokered Private Placement
Nov 4, 2024 02:41PM Bright Minds Biosciences Closes US$35 Million Non-Brokered Private Placement
Oct 31, 2024 04:19PM Form SC 13G Monopar Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.
View More Recent Stories View Older Stories